EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos
EuroPCR 2023: COAPT 5-year follow-up
EuroPCR 2023: Defining the future
EuroPCR 2023: Tricuspid valve
EuroPCR 2023: Vascular access
EACTS 2022: Tendyne™ vs on-pump MVR
Navitor™: Voice of the Experts Lars Sondergaard
Tendyne™: Animation
Mechanical Heart Valve Patient Story: Sadie
CardioMems™
Webinar: Aortic & Mitral Valve Disease
PCRLV 2021: Transcatheter mitral valve replacement
EACTS 2021: Transcatheter mitral valve implantation